Opus Genetics, Inc. (IRD)
2.50
+0.14
(+5.93%)
USD |
NASDAQ |
Jan 22, 16:00
2.50
0.00 (0.00%)
After-Hours: 18:52
Opus Genetics EPS Diluted (Quarterly): -0.2471 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Zymeworks, Inc. | -0.2587 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.45M |
| Revenue (Quarterly) | 3.079M |
| Total Expenses (Quarterly) | 20.53M |
| Enterprise Value | 133.01M |
| Gross Profit Margin (Quarterly) | 99.58% |
| Profit Margin (Quarterly) | -566.9% |
| Earnings Yield | -68.75% |
| Normalized Earnings Yield | -42.93 |